Roche Diagnostics produces new technology to help monitor patients on
Roche Diagnostics is committed to following the latest technologies to ensure
easy and handy solutions that serve patients’ needs. The ability to move testing
closer to the patient, so-called point-of-care testing (PoCT), has been possible
with continuous advances in technology that have produced steadily more
sophisticated devices measuring an increasing range of analytes.
The focus of Ambulatory Care within the PoCT is to bring clinical decision
making closer to the patient, improve workflow efficiencies for the health care
professional and improve clinical outcomes for the patient. With the increasing
incidence and prevalence of cardiovascular disease, the need to screen and
monitor patients effectively, assess risk and manage long term conditions, has
also increased. Roche Diagnostics’ portfolio of products provides a solution to
support this growing need.
Home testing is a key solution that is delivered to move testing closer to
patients. The CoaguChek XS system is a great example that resembles practical
home based testing. CoaguChek XS is a convenient, portable and user-friendly
instrument for monitoring oral anticoagulation therapy. It determines the value
PT/ INR (blood clotting time) testing from a drop of capillary whole blood –
simple, precise and reliable. The CoaguChek XS system is ready for use anywhere
at any time. Patients can use it for self-monitoring at home or on vacation.
Long-term oral anticoagulant treatment (blood-thinning drugs) is a strain for
many patients, for instance when it comes to the frequent checks of therapeutic
levels. Coagulation and monitoring are an area where Roche can offer impressive
medical value: CoaguChek systems offer rapid, accurate and almost painless,
minimally invasive measurement of the International Normalized Ratio (INR)
clotting time as it is particularly important for patients taking bloodthinning
drugs like warfarin as it helps doctors determine if the prescribed dose is
working properly, therefore improving the management of oral anticoagulation
therapy, for indications such as Atrial Fibrillation, Mechanical Heart Valves
The meters measure the thromboplastin time (prothrombin time, INR, % Quick
value) using capillary blood from the fingertip or non-anticoagulated venous
whole blood. IT connectivity to the PC or data management system is provided
either with the CoaguChek XS Connect device at the patient’s home computer or by
using the handheld base unit (HBU) in the professional setting. The latter
presentation describes the CoaguChek XS Plus/ Pro system’s IT connectivity data
communication, pre-requisites and support, which is suitable for the Hospitals
and key health centers that requires connectivity to laboratory systems rather
than the Home Testing simple connectivity.
The U.S. Food and Drug Administration (FDA) has granted CLIA-waived status to
the CoaguChek XS Plus system. The Clinical Laboratory Improvement Amendments (CLIA)
are regulatory standards that apply to all clinical laboratories testing
performed on humans in the U.S., except clinical trials and basic research. The
waiver means that the monitoring technology may now be used in a broader range
of clinical settings, such as labs that do not meet the requirements to do
moderate- or high-complexity testing as defined by CLIA.
The CoaguChek XS Plus system provides results in about a minute and has a 97%
correlation to lab analyzer results. In addition, recent enhancements to the
system include the ability to hold up to 1,000 patient results and the reduction
of the sample size requirement to eight microliters. The CoaguChek XS Plus
system offers state-of-the art connectivity, particularly to the cobas IT 1000
application outside the United States.
In the US, the system works with the RALS-Plus software, a commercial
information management system, which provides reporting and device management
capabilities. It helps hospital staff streamline the regulatory compliance
process, capture reimbursable costs, and improve their organizational
The CoaguChek XS Plus system uses two-level, built-in quality controls to help
ensure the accuracy of PT/INR test results, but also offers optional liquid
quality controls for facilities with policies requiring the use of external
quality control measures. Today, in the U.S., more CoaguChek test strips are
sold for point-ofcare anticoagulation testing than all other brands combined.
Carestream wins “Best in KLAS” for DRX-Evolution System
For the second time in one month, Carestream Health has again earned a top
rating from medical professionals using a Carestream digital X-ray system as
reported by KLAS, an independent research organization that monitors healthcare
The recent “2013 Best in KLAS Awards: Medical Equipment & Infrastructure” report
cites the Carestream DRX-Evolution as receiving the highest overall score
against seven competitors in the digital X-ray category, with 100% of users
stating they would buy Carestream’s system again. The report is compiled from
the feedback of thousands of healthcare providers at physician offices, clinics,
hospitals and IDNs throughout the United States and Canada.
KLAS has a longstanding reputation for accurately and impartially measuring
vendor performance, and offers ratings on more than 250 healthcare technology
vendors and over 900 products and services. Headquartered in Orem, Utah, KLAS
processes have been independently audited to ensure that KLAS provides a
transparent window into what users actually think of products.
“Healthcare providers using our digital X-ray systems have again expressed their
high level of satisfaction with the many benefits our products deliver,
including exceptional image quality and rapid access to images and information,”
said Diana L. Nole, President, Digital Medical Solutions, Carestream. “Our
people are passionate about delivering the best X-ray and IT solutions to the
market, and we have many new products in our pipeline that will benefit
patients, physicians and medical staff for many years to come.”
Earlier, the company’s Carestream DRX-Evolution system scored highest for
overall performance in another KLAS survey of more than 200 radiology
professionals. One user stated: “I would compare the DRX-Evolution to Apple’s
products. It is very intuitive and it tells users in layman’s terms how to get
- For more information, visit
Timesco single-use laryngoscopes provide 100% infection control
Timesco Healthcare, England, has been at the forefront of laryngoscopes design,
manufacture and innovative developments in intubation for the past four decades.
Today Timesco manufactures the best single use laryngoscopes systems available,
with the traditional bulb in the blade, ‘Europa’ and fiber optic, ‘Callisto’
systems, enabling millions of intubations to be performed by medical
Both the Europa and Callisto systems feature unique low profile, “non touch”
blades and are complemented with the single use Callisto and Europa handles.
Specialist blades for difficult intubation e.g. Eclipse tilting tip are also
available in Callisto designs.
Timesco single use laryngoscopes are supplied clinically clean in individual
packaging and conform to ISO international standards of fittings and
Timesco is a progressive and innovative company; we have recently
introduced new Energy Efficient Systems for extended battery life, kinetic
energy power systems and new rechargeable systems to power our laryngoscopes and
diagnostic systems. New LED handles and LED single use laryngoscopes blades have
also been added to the ranges. Timesco will be
at: Fime, Miami, USA, 7-9 August 2013.
- For more information, visit:
Phibo expands global presence with Middle East subsidiary
Phibo, with 20 years of experience in dental products and services, offers
solutions from bone regeneration to the final prosthesis itself, without
neglecting implant systems, and always taking patients’ health, comfort and
aesthetics into consideration. Phibo offers predictability in the results,
optimisation of treatment times, reduction of the possibility of error, in short
we ensure better quality for the patient.
For Phibo what is really important is offering reliable and flexible integral
solutions that improve the work of our clients, making difficult work easy.
Phibo is present in the international market strongly than ever. This year Phibo
is expanding its global presence in to Middle East, Colombia, France, Germany
and Benelux, including its nowadays operations in Italy, Portugal and Spain.
The international dental company manufactures implant systems and CAD-CAM
prostheses as well as other digital solutions.
Phibo CAD-CAM prostheses are 100% customized solutions which satisfy all
patients’ needs with the most attractive results. Moreover, Phibo provides all
their CAD-CAM restorations on any implant system thanks to the Phibo Library,
the most complete list of implant systems of the market.
The most revolutionary product on the prosthetics market is Adhoc, screw-mounted
Cobalt Chrome by Phibo, for all screwmounted metal-ceramic restorations. This
product combines the best of different technologies to provide the best results
where needed: best ceramic grip and best fit for the connection area. This
product is available for all types of structures: from single parts to anatomic
structures with any number of parts, and complicated hybrid structures to the
simplest of bars.
In addition to Adhoc, Phibo introduces Cronia, the temporary aesthetic
prosthetic that provides the most similar result as possible to natural teeth,
while patients are waiting for the definitive restoration. This product is made
of Polymethyl methacrylate (PMMA) 100% biocompatible and non-allergenic. Cronia
helps to care for, model and maintain the soft tissues.
Phibo offers the most comprehensive CAD-CAM solutions: from cemented structures
to restorations on implants, from hybrid structures to removable bars in all
materials -Cobalt Chrome, Zirconia, PMMA, Titanium as well as cemented
restorations in IPS e.max CAD.
- For more information, visit: www.Phibo.com
Siemens’ Symbia Intevo, the world’s first xSPECT system, integrates SPECT and
At the 2013 annual meeting of the Society of Nuclear Medicine and Molecular
Imaging (SNMMI), in June, in Vancouver, Canada, Siemens Healthcare introduced
two new platforms with the potential to change how molecular imaging is
Symbia Intevo – the world’s first xSPECT system – combines the high sensitivity
of single-photon emission computed tomography (SPECT) with the high specificity
of CT, completely integrating the data from the two modalities, to generate high
resolution and, for the first time, quantitative images.
In traditional SPECT/CT imaging, the SPECT image has always been reconstructed
at a low resolution matrix – much lower than the CT portion of the exam. As a
result, the CT resolution must be downgraded dramatically to the level of SPECT
to enable mechanical fusion of the two modalities. Siemens’ new Symbia Intevo
xSPECT system reconstructs both the SPECT and CT portions of the image into a
much higher frame of reference than previous systems for precise, accurate
alignment facilitating the extraction and deep integration of medically relevant
information. This ability is also the basis for differentiating between tissue
boundaries in bone imaging. With xSPECT Bone, physicians can potentially provide
additional support for detection and distinguishing between cancerous lesions
and degenerative disorders.
Symbia Intevo’s precise alignment of SPECT and CT provides physicians with
essential volumetric information from the CT scan, enabling accurate and
consistent quantitative assessment – a numerical indication of a tumour’s level
of metabolic activity. With accurate quantitative assessment, the physician can
apply quantitative information to assess whether a patient’s course of treatment
has regressed, stabilized or grown – something that is difficult to do with a
purely visual assessment of the tumour.
While Symbia Intevo uses more CT data than ever before, Siemens is still able to
limit patient dose by offering Combined Applications to Reduce Exposure (CARE).
These applications, which are unique to Siemens, include the CARE Dose4D
technique, which can reduce patient CT radiation dose by up to 68%.
- For more information, visit:
GE Healthcare unveils 2 new 1.5T MR systems
Two new 1.5T MR scanners from GE Healthcare, the Optima MR360 Advance
and Brivo MR355 Inspire, have recently received US FDA 510(k) clearance.
Redesigned with new enclosures symbolizing GE’s Humanizing MR strategy,
both systems are engineered to address the demand for increased
performance, and reduced total cost of ownership for the facility while
providing a comfortable experience for the patient.
“Overall, I was pleasantly surprised with the image quality, especially
the quality of abdomen and pelvis images, which are excellent when
compared to 3T,” said Tamotsu Nomura, Chief Technologist at Ishikawa
Hospital in Osaka, Japan who owns the first Optima MR360 Advance in the
Dr Gloger of Verbundklinikum Landkreis Ansbach Klinik, Rothenburg, who
owns the first system in Germany said: “After a smooth and fast
installation, my radiographers learned very quickly how to scan,
including those with minimal MR experience.”
The Optima MR360 Advance is designed to deliver a comfortable patient
experience and advanced performance. This system offers a newly-designed
Express suite of coils with 16 channel head and neck array, anterior
array, and flex coils that enable faster workflow. Additionally, the
Optima MR360 Advance is available with a portfolio of 18 new clinical
applications including the Needle Free suite of applications that
strives to improve patient experience by reducing the need for biopsy,
contrast, and sedation. The Optima MR360 Advance also features the
acclaimed OpTix RF, which offers analog to digital signal inside the
scan room to minimize noise and signal degradation resulting in
highquality clinical images, but away from the patient to enhance
The Brivo MR355 Inspire is designed to be an easy-to-use 1.5T MR system.
This system also features OpTix RF as well as READY Interface, which
streamlines workflow by offering simplified control of the scan
parameters that may allow for greater consistency from technologist to
technologist and ultimately from patient to patient. The Brivo MR355
Inspire system is engineered to combine the diagnostic benefits of
high-performance MR technology with a low total cost of ownership.
Both the Optima MR360 and the Brivo MR355 are ‘ecomagination’ certified
and are engineered to drive low operating costs by using eco-friendly
technologies like efficient gradients, water-cooling systems, super
capacitors, and power distribution units.
of upload: 18th Jul 2013